Share ownership Edwards Lifesciences Corporation

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 05:00:02 24/01/2026 HKT			5-day change	1st Jan Change
83.66 ^USD	-0.92%		-0.82%	-1.87%

01-22	Leerink Partners Adjusts Edwards Lifesciences Price Target to $88 From $87, Maintains Market Perform Rating	MT
01-22	Venus Medtech Clarifies U.S. Patent Lawsuit Involving Subsidiary	MT

Share class: Edwards Lifesciences Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	654,300,000	584,388,561 ( 89.32 %)	64,500,000 ( 9.858 %)	89.32 %

Major shareholders: Edwards Lifesciences Corporation

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 12.13 %	70,363,210	12.13 %	5 998 M $
BlackRock Advisors LLC 6.657 %	38,631,680	6.657 %	3 293 M $
STATE STREET CORPORATION 4.415 %	25,619,632	4.415 %	2 184 M $
JPMorgan Investment Management, Inc. 4.331 %	25,130,238	4.331 %	2 142 M $
Wellington Trust Co., NA 3.585 %	20,804,416	3.585 %	1 774 M $
BNY Mellon Investment Adviser, Inc. 3.276 %	19,010,659	3.276 %	1 621 M $
BlackRock Life Ltd. 2.535 %	14,712,845	2.535 %	1 254 M $
Fidelity Management & Research Co. LLC 2.512 %	14,578,812	2.512 %	1 243 M $
Jennison Associates LLC 2.405 %	13,958,774	2.405 %	1 190 M $
Geode Capital Management LLC 2.212 %	12,837,145	2.212 %	1 094 M $
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
XP Allocation Asset Management Ltda. 0.000049 %	1,128	0.000049 %	24 377 $

Breakdown by shareholder type

Institutional	73.04%
Other	9.84%
State Street Corp.	4.41%
Schweizerische Nationalbank	0.29%
Individuals	0.25%
Sumitomo Mitsui Trust Group, Inc.	0.24%
Skandinaviska Enskilda Banken AB	0.19%
Manulife Financial Corp.	0.17%
Governments	0.16%
SEI Investments Co.	0.11%
Swedbank AB	0.09%
Polar Capital Holdings Plc	0.05%
Danske Bank A/S	0.05%
Peapack-Gladstone Financial Corp.	0.05%
Banco Bilbao Vizcaya Argentaria SA	0.04%
The Bank of Nova Scotia	0.03%
ABN AMRO Bank NV	0.03%
Baader Bank AG	0.02%
Banque Cantonale Vaudoise	0.01%
ING Groep NV	0.01%
Hancock Whitney Corp.	0.01%
Regions Financial Corp.	0.01%
Unknown	10.9%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	64.65%
United Kingdom	10.04%
Germany	2.26%
Norway	1.73%
Canada	1.55%
France	1.42%
Switzerland	1.08%
Sweden	0.94%
Australia	0.9%
Denmark	0.8%
Japan	0.73%
Luxembourg	0.47%
Netherlands	0.43%
Spain	0.38%
Belgium	0.26%
South Korea	0.25%
Individuals	0.25%
Ireland	0.17%
New Zealand	0.15%
Taiwan	0.11%
Singapore	0.08%
Finland	0.07%
Italy	0.07%
Austria	0.07%
United Arab Emirates	0.07%
South Africa	0.05%
Czech Republic	0.03%
Hong Kong	0.02%
Mexico	0.02%
Portugal	0.01%
China	0.01%
Puerto Rico	0.01%
Liechtenstein	0.01%
Slovenia	0.01%
Israel	0.01%

Based on 1000 largest holdings

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (75.5%); - hemodynamic monitoring systems (6.5%); - other (18%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.9%), Europe (24.3%), Japan (6.3%) and others (10.5%).

Employees

15,800

Sector

Advanced Medical Equipment & Technology

Calendar

02-10 - Q4 2025 Earnings Release

More about the company